An Existing Drug May Have Therapeutic Potential in Mitochondrial Disease

Newswise imageNew preclinical findings from extensive cell and animal studies suggest that cysteamine bitartrate, a drug already used for a rare kidney disease, could benefit patients with some mitochondrial disorders. No proven effective treatments yet exist for these complex conditions with severe energy deficiency

Source link

Related posts

Few Mandatory Pediatric Postmarketing Studies Completed


For children born with HIV, adhering to medication gets harder with age


Infants' advances in speech processing play role in language-cognition link


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy